NEXTCELL PHARMA AB revenue breakdown overview

NEXTCELL PHARMA AB revenue for the last year amounted to 11.30 M SEK, the most of which — 10.66 M SEK — came from its highest performing source at the moment, Cell Therapies, the year earlier bringing 10.11 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought NEXTCELL PHARMA AB 10.66 M SEK, and the year before that — 10.11 M SEK.